Skip to main content

Table 1 Prioritized variants in the positive control

From: A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer

Gene

mRNA Protein

rsID (dbSNP 142)

Category

Consequence

Ref

BRCA1

c.5136G > A

rs80357418

Nonsense

151 AA short

[142]

p.Trp1712Ter

BRCA2

c.3218A > G

rs80358566

SRFBS

Repressor action of hnRNPA1 at this site abolished (5.2 to 0.4 bits). Blocking action of PTB removed as site is abolished (5.5 to -7.5 bits) and may uncover binding sites of other SRFs.

 

p.Gln1073Arg

Missense

Listed in ClinVar as conflicting interpretations (likely benign, unknown) and in BIC as unknown clinical importance. 2 in silico programs called deleterious. The variant occurs between repeat motifs BRC1 and BRC2 of BRCA2, a region in which pathogenic missense mutations have not yet been identified.

[143]

SRFBS

Repressor action of hnRNPA1 at this site abolished (5.2 to 0.4 bits). Blocking action of PTB removed as site is abolished (5.5 to -7.5 bits) and may uncover binding sites of other SRFs.